** Shares of Noxopharm NOX.AX rise nearly 46% to A$0.07, their biggest pct gain since October 4, 2023
** Stock hits highest level since June 6
** Biotech co says first dose of SOF-SKN, a drug candidate for autoimmune diseases was administered to trial participant
** Around 422,086 shares traded, 2.2x the 30-day avg
** YTD, shares down 24.7%, including today's move
(Reporting by Ananya Verma in Bengaluru)
((Ananya.Verma@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.